US EditionNew Synthetic DNA Vaccine Against Powassan Virus
MINNESOTA, AUG 9 – Researchers found a key viral pocket that disrupts Powassan virus assembly, aiding vaccine or drug development as cases rise with 26 reported in Minnesota and Wisconsin this year.
- Researchers developed and evaluated a novel DNA-based vaccine targeting the Powassan virus, with findings published on October 30, 2020.
- The vaccine development responded to increasing POWV cases in Minnesota and Wisconsin amid no existing treatments and a 300% infection rise over 16 years.
- Researchers identified a lipid pocket crucial to virus assembly, which, when disrupted by mutation, caused the virus to collapse, suggesting a drug target.
- The CDC states about 10% of severe POWV cases result in death and half suffer long-term health issues like memory loss and headaches.
- This vaccine offers a promising prevention approach amid spreading POWV infections transmitted rapidly by deer ticks, emphasizing the need for biologics and vaccination.
Insights by Ground AI
Does this summary seem wrong?
18 Articles
18 Articles
Duluth News Tribune+16 Reposted by 16 other sources
U of M researchers ID weakness in Powassan virus that could lead to vaccine, treatment
The tick-borne virus, which can cause encephalitis, meningitis and death, is spreading throughout Minnesota and Wisconsin, but there are no drugs to treat or prevent it.
·Cherokee County, United States
Read Full Article
Coverage Details
Total News Sources18
Leaning Left0Leaning Right8Center6Last UpdatedBias Distribution57% Right
Bias Distribution
- 57% of the sources lean Right
57% Right
C 43%
R 57%
Factuality
To view factuality data please Upgrade to Premium
